Table 2.
Comparison of PD-related peritonitis rates and PD technique survival
Country | Reference | Number of cases | Time of review | Peritonitis rate1 | Common causative organisms | Technique survival |
---|---|---|---|---|---|---|
Hong Kong | Ho et al. [22] | 3,573 | 1999–2011 | 35.8 | Staphylococcus (48.2%) | 5 years: 31.3% |
Pseudomonas (35.8%) | 10 years: 3.1% | |||||
culture-negative (11.1%) | 15–20 years: 0.7% | |||||
Australia | McDonald and Hurst [23] | 5,515 | 2007–2011 | 20 | Gram-positive (53.4%): CoNS, S. aureus, Streptococci | 1 year: 85.0% |
3 years: 54.5% | ||||||
Gram-negative (23.6%): E. coli, Pseudomonas, Klebsiella | 5 years: 36.5% | |||||
New Zealand | McDonald and Hurst [23] | 1,756 | 2007–2011 | 19.4 | n.a. | 1 year: 91.0% |
3 years: 66.5% | ||||||
5 years: 44.5% | ||||||
Korea | Han et al. [40] | 1,656 | 1981–2005 | 31.6 | Gram-positive (42.6%): Staphylococcus (35.2%) | 1 year: 94.9% |
Gram-negative (17%): E. coli, Pseudomonas culture negative (37.3%) | 3 years: 83.7% | |||||
5 years: 71.9% | ||||||
10 years: 48.1% | ||||||
Japan | Mizuno et al. [41] | 561 | 2005–2008 | 42.8 | Gram-positive (42.7%): Staphylococcus (21.5%), Streptococcus (12.8%), culture-negative (32.0%) | n.a. |
Japan | Nakamoto et al. [55] | 5,391 | 2003 | n.a. | 10% dropout rate/year | |
Taiwan | Hsieh et al. [56] | 391 | 2001–2010 | 61.2 | Gram-positive (42.8%): Streptococcus > Staphylococcus | n.a. |
Gram-negative (29%): Pseudomonas > Acinetobacter | ||||||
India | Vikrant [10] | 60 | 2002–2011 | 30.6 | Significant tuberculosis and fungal peritonitis risks | 1 year: 77% |
2 years: 53% | ||||||
3 years: 25% | ||||||
4 years: 15% | ||||||
5 years: 10% | ||||||
India | Abraham et al. [28] | 309 | 1999–2004 | 30 | 1 year: 98.6% | |
5 years: 93.3% | ||||||
10 years: 86.6% | ||||||
China | Zhang et al. [27] | 421 | 2001–2011 | 62.9 | Gram-positive (21.1%) | 1 year: 86.7% |
Gram-negative (18.4%): fungi (13%), culture-negative (47.5%) | ||||||
3 years: 68.8% | ||||||
5 years: 55.7% | ||||||
10 years: 37.4% | ||||||
Thailand | Dhanakijcharoen et al. [20] | 12,753 | 2008–2011 | 25.8 | n.a. | 1 year: 92% |
2 years: 85% | ||||||
3 years: 80% |
CoNS = Coagulase-negative staphylococci; n.a. = not assessed.
Patient-months per episode.